NASDAQ
Creative Medical Technology Holdings, Inc. (CELZ) has a price/fcf ratio of -0.80x as of Monday, May 25, 2026. This represents a 30.29% increase compared to its 12-month average of -1.14x. The price-to-free-cash-flow ratio measures a stock's price relative to its free cash flow per share, reflecting how efficiently a company generates cash.
No price data available for this timeframe.